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Abstract 
Aged rats exhibit a decreased muscle microvascular O2 partial pressure (PO2mv) at rest as 
well as during contractions compared to young rats and this may contribute to their 
reduced exercise tolerance. Age-related reductions in nitric oxide (NO) bioavailability 
due, in part, to elevated reactive O2 species (ROS) constrain muscle blood flow (Q& m).  
Therefore, antioxidants may restore NO bioavailability, Q& m and ameliorate the reduction 
in PO2mv and hence the decrease in exercise tolerance seen in aged rats. PURPOSE: To 
test the hypothesis that antioxidants would elevate Q& m at rest and during contractions and  
therefore PO2mv in aged muscle. METHODS: PO2mv and Q& m were measured in the 
spinotrapezius while muscle oxygen consumption (V. O2m) was estimated in 20 
anesthetized male Fisher 344 x Brown Norway hybrid  (F344xBN) rats at rest and during 
1 Hz contractions before and after antioxidant intravenous infusion (76mg/kg vitamin C 
and 52mg/kg tempol). Moreover, muscle force production was measured in a subset of 
animals. RESULTS: Before infusion, contractions invoked a biphasic PO2mv that fell 
from 30.6 ± 0.9 mmHg to a nadir of 16.8 ± 1.2 mmHg with an ‘undershoot’ of 2.8 ± 0.7 
mmHg below the subsequent steady-state (19.7 ± 1.2 mmHg).  Antioxidants elevated 
baseline PO2mv to 35.7 ± 0.8 mmHg (P<0.05) and reduced or abolished the ‘undershoot’ 
(P<0.05) without changing the steady-state contracting PO2mv. Antioxidants did not  
change Q& m at rest but during contractions Q& m was reduced from 157 ± 28 to 91 ± 15 ml  
min-1 100g-1  (P<0.05).  Antioxidants produced no significant effect on V. O2m. However, 
antioxidant supplementation produced a 16.5% decrease (P<0.05) in muscle force  
 production that occurred within the first contraction and remained throughout the 
duration of stimulation. In addition, the ratio of muscle force production to V
.
O2m  
(F/V. O2m) actually increased from 0.92 ± 0.03 to 1.06 ± 0.6 (P<0.05) following infusion  
 
of antioxidants. CONCLUSION: Antioxidant supplementation significantly alters the  
balance between muscle O2 delivery and V
.
O2 at rest and during contractions, which 
modifies the microvascular PO2mv profile. Specifically, antioxidants elevate PO2mv, which 
improves the potential for diffusive blood-myocyte flux. This effect arises, in part, from 
the unanticipated fall in muscle force production consequent to antioxidant 
supplementation. 
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CHAPTER 1 - Introduction 
Most individuals experience significant age-related reductions in exercise  
tolerance after attaining adulthood.  These reductions in exercise capacity are associated  
with decrements in both maximal oxygen (O2) uptake (V
.
O2max) and physical endurance 
 
capacity at submaximal work rates (3, 40, 45, 64). Although aged individuals possess a 
significantly lower V
.
O2max when compared to their younger counterparts (3, 14, 21, 46,  
 
59) some do not demonstrate a reduced maximal cardiac output ( Q& ) even though their 
maximal heart rate (HRmax) decreases with age (14, 21, 45, 59). Specifically, McGuire et 
al. (59) showed that maximal stroke volume (SVmax) increased with age, compensating 
for the decreased HRmax and thereby maintaining maximal cardiac output and whole body 
O2 delivery. This suggests that age-related declines in exercise tolerance, in so far as they 
relate to the O2 transport capacity, may be ascribed to peripheral alterations that act to 
decrease the fractional extraction of O2 from the blood (i.e. arterial-mixed venous 
difference; a-vO2) (59). This reduced a-vO2 difference may be accompanied by 
reductions in mitochondrial volume density and function in addition to a decreased lineal 
density of flowing capillaries (74).  
At rest, when compared to their young counterparts, aged rats exhibit a: 1) higher 
muscle capillary red blood cell (RBC) velocity (VRBC) and flux (FRBC) (74) 2) reduced 
partial pressure of oxygen (PO2mv) in the resting muscle microvasculature that is 
maintained throughout the rest-contractions transition (9). Thus, a decreased PO2mv 
driving pressure is present in aged rats when compared to their younger counterparts and 
one possible explanation for this phenomenon is age-related reductions in both tissue 
and/or vascular nitric oxide (NO) bioavailability are present (12, 27, 28, 79, 80, 84).   
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Based on these previous findings (9), one would hypothesize that bulk blood flow 
(Q& ) during exercise decreases with age. Contrary to this hypothesis, it has been shown 
that bulk Q&
 
to the hindlimbs of rats during submaximal exercise is not decreased in the 
aged when compared to the young (61). There is, however, a redistribution of blood flow 
from the muscles containing a majority of highly oxidative fibers to those muscles 
containing a majority of highly glycolytic fibers. These findings suggest that age-related 
changes may be occurring at the microcirculatory level that are likely to influence the O2 
delivery-to-O2 utilization relationship during muscle contraction (9).   
In healthy young individuals muscle blood flow ( Q& m) increases immediately at 
 the onset of muscle contractions and is sustained during the steady-state (50, 51, 78)  
such that the Q& m is directly related to the rate of oxidative metabolism in muscle (V
.
O2m) 
(30, 70). In aged individuals Q& m is sometimes found to be lower than that in young 
subjects during exercise (36, 53, 66, 67).  However, in these and other studies in humans 
technical considerations precluded assessment of whether there was an age-related 
redistribution of Q& m within or between individual muscles during exercise.  
The overall reduction in Q& m found in aged individuals is thought to be related 
directly to compromised arteriolar vasomotor control (25, 60, 67). Since the production 
and release of NO from vascular endothelial cells is considered to be a major contributor 
to the skeletal muscle hyperemia seen in healthy young individuals during exercise, the 
possibility exists that there may be an impaired NO-mediated vasodilation in aged 
individuals (43, 44, 77). In support of this notion it has been shown that the relative 
contribution of NO to the vascular control of skeletal muscle is reduced in aged 
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individuals (12, 27, 28, 79, 80, 84) and thus decreased NO bioavailability may potentially 
explain the age-related reductions in the Q& m response (25, 61, 67).   
The mechanism(s) responsible for this decrease in NO bioavailability in aged 
individuals may result, in part, from an increased mitochondrial leakage of reactive 
oxygen species (ROS) (27, 35, 80). ROS can influence NO bioavailability in two ways. 
First, ROS scavenge NO to produce peroxynitrite which reduces NO bioavailability 
whilst simultaneously producing another ROS. Second, ROS decrease the concentration 
of the NO synthase (NOS) co-factor tetrahydrobiopterin (BH4), which is essential for the 
production of NO by NOS (38, 39). If either of these mechanisms contribute to the 
reduction in NO bioavailability in aged skeletal muscle, supplementation with 
antioxidants, sufficient to decrease the amount of circulating ROS, may help restore 
endothelial (i.e. arteriolar) function and NO bioavailability in aged individuals (27, 79). 
The partial pressure of oxygen in the microvasculature supplying muscle (PO2mv)  
is dependent upon the ratio of oxygen delivery to the muscle ( Q& O2m) and V
.
O2m  
(i.e.,Q& O2m/V
.
O2m).  The maintenance of this ratio and consequently PO2mv, during 
exercise is crucial in order to provide an adequate pressure head to drive O2 flux across 
the blood-myocyte interface and deliver O2 to the mitochondria during contractions (i.e.  
transition and steady-state) (7, 8, 31, 65, 85). Upon the initiation of muscle contractions  
in young healthy rats, Q& O2m increases rapidly and in parallel with V
.
O2m such that there is 
a ~ 10-20 second delay in the fall of PO2mv, (30). As the muscle contractions continue 
PO2mv falls and eventually reaches a steady state. 
 In young, healthy individuals performing moderate-intensity exercise it is  
generally accepted that the increased rate of in Q& O2m does not limit V
.
O2m (11, 50). Thus,  
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in young healthy individuals, Q& m and Q& O2m increase at the same rate or occasionally  
faster than V
.
O2m at least for the first 10-20 s, which prevents PO2mv from falling  
(Q& O2m/V
.
O2m) (9-11). Beyond the first 10-20 s, the Q& O2m/V
.
O2m ratio falls and PO2mv 
demonstrates an exponential decrease to the steady-state, reflecting the increased 
fractional O2 extraction. The net effect of this behavior is that PO2mv in young animals is 
maintained at high levels across the rest-contraction transition thereby improving 
mitochondrial O2 delivery, which permits more reliance on oxidative metabolism. 
However, aging is associated with an altered (i.e., lowered) PO2mv profile (9) that 
potentially reflects peripheral vascular derangements. In aged muscle there is a reduced 
PO2mv following the onset of contractions, which results in a lower O2 driving pressure  
across the blood-muscle interface (9, 15). This reduction in O2 driving pressure is  
expected to slow V
.
O2 kinetics, increase the O2 deficit (26) and increase mitochondrial 
ROS production (16). If interventions aimed at restoring vascular endothelial function do, 
in fact, augment Q& O2m this should improve PO2mv kinetics (i.e. raise the absolute PO2mv 
across the transtion) following the onset of muscle contractions. The improved PO2mv 
kinetics would potentially increase blood-myocyte O2 flux in aged individuals and 
thereby potentially enhance exercise tolerance.  
Ferreira and colleagues have shown previously that increasing NO bioavailability 
improved the PO2mv kinetics profile in both young healthy rats and those with 
experimentally-induced heart failure (29, 30). The opposite effect occurred with NOS 
inhibition (30). One potential method for augmenting NO-mediated vasodilation in 
skeletal muscle is via antioxidant supplementation. Antioxidant supplementation allows 
an increase in NO bioavailability by binding to ROS thereby inactivating them (27, 79). 
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In the present investigation we examined the role of antioxidant supplementation on Q& O2 
and PO2mv across the rest-to-contractions transition in the spinotrapezius muscle of aged 
rats. Specifically, we tested the hypotheses that after antioxidant supplementation: 1) the 
reduced PO2mv normally found in the resting muscle of aged rats would be alleviated; 2) 
the elevated resting PO2mv of aged rats would be associated with an increase in resting  
Q& m to muscle; 3) there would be an increase in Q& m to the contracting muscle which  
would elevate the Q& O2m/V
.
O2m ratio and thus PO2mv in the exercising steady-state; 4) the 
dynamic PO2mv undershoot and prolonged PO2mv kinetics that are commonly found in the 
transition from rest to exercise in aged rats (9) would be reduced or eliminated. 
 
 
 
  6 
CHAPTER 2 - Review of Literature 
The reduction in exercise capacity with aging is associated with reductions in both  
maximal aerobic capacity and submaximal endurance capacity (3, 40, 45, 64). However,  
since the reductions in V
.
O2max and endurance capacity found with aging may occur 
through different physiological mechanisms, their relative importance and contributions 
to the overall reduction in exercise capacity found in aging individuals remain obscure. 
Therefore, it is important to look at both the intra-cellular and the extra-cellular aspects 
that effect endurance capacity. 
Intra-cellular Properties 
Sarcoplasmic Reticulum 
The sarcoplasmic reticulum (SR) functions to uptake and release calcium (Ca2+) 
to help either initiate or sequester skeletal muscle contractions. The SR does not appear to 
have any structural deformations that occur with aging (55). There is no evidence that the 
number of SRs are changed with age (32, 63). However, there is a lower rate of Ca2+ 
uptake that occurs in the SR of slow twitch muscle fibers (63).  The enzyme responsible 
for Ca2+ uptake is Ca2+-ATPase. This enzyme is found in lower concentrations (47) and 
appears to be less stable in the skeletal muscle of aged individuals when compared to 
their younger counterparts (55).  
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Sodium-potassium Pumps 
The aging process causes a decrease in the number of sodium-potassium (Na+/K+) 
pumps along with the concentration of Na+/K+ ATPase (64). The major role of these 
Na+/K+ pumps is to maintain the cells membrane potential. Na+/K+ ATPase is an enzyme 
that plays a similar role when compared to Ca2+-ATPase. Their role in skeletal muscle 
fibers is to allow for an action potential to be transported from one region to another 
region allowing for a muscle contraction. There is also a decrease in the ability of motor 
axons and nerve muscular junctions to function properly that occurs with aged humans 
and animals (5, 71). Any alterations within the muscle fiber to produce action potentials 
could produce a decrease in skeletal muscle contractile function. The end result being a 
decreased muscle force production and decrements in exercise tolerance. 
Sarcopenia 
Another age related phenomenon that contributes to reduce muscle function is the 
atrophy of muscle mass, which is known as sarcopenia (18, 72).  The defects in aged 
skeletal muscle mentioned above may play a role in sarcopenia as well as the trend of 
physical inactivity in aged individuals. Skeletal muscles contain cells called satellite cells 
and it is these cells job to inhibit sarcopenia by regenerating skeletal muscle fibers (57). 
In rat skeletal muscle it has been shown that the number of satellite cells is significantly 
reduced with age (1, 33). Moreover, this reduction leads to an increased rate of atrophy 
(20, 33).  
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Myosin – Actin 
Although many of the mechanisms associated with muscle contraction become 
dysfunctional with advancing age, other components associated with excitation-
contraction coupling are maintained. For example, myosin and actin filaments which 
comprise the muscle contractile elements are not affected with age (81). In the presence 
of Ca2+, myosin and actin interact with each other forming cross bridges which produces 
a muscle contraction. Since myosin, actin and the sarcoplasmic reticulum are not affected 
by age there must be other villains that cause the reductions in both muscle performance 
and exercise tolerance in aged individuals. These villains are the reduced ability of Ca2+ - 
ATPase and Na+/K+ -ATPase to work properly along with lowered number of properly 
working Na+/K+ pumps.  
Extra-cellular Properties 
In conjunction with decrements in skeletal muscle function, aged individuals  
possess a significantly lower V
.
O2max when compared to their young counterparts (3, 21,  
46, 59). As with muscle performance, it is important to concentrate on the factors that  
affect V
.
O2max.   
Fick Equation 
The Fick equation is the gold standard when evaluating V
.
O2max. The Fick  
equation states V
.
O2 = Q&  x a-vO2, where Q&  is cardiac output and/or the blood flow and  
a-vO2 is the arterial – mixed venous O2 difference. Moreover, Q&  = HR x SV, where HR 
is heart rate and SV is stroke volume. Maximal heart rate has been shown to decrease 
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with age (21, 45, 59, 75). McGuire et al. demonstrated through a 30 year old longitudinal 
study that SVmax increases with age, compensating for the decreased HRmax, thereby  
maintaining cardiac output (59). The presence of a maintained cardiac output indicates  
that central adaptations are not the cause for the reduced V
.
O2max seen in aged individuals.  
The answer for this decrease V
.
O2max may lie in the impaired effectiveness of the 
peripheral Q&  (59).  
When examining the second half of the Fick equation it becomes evident that 
aged individuals suffer from a reduced a-vO2 difference that is accompanied by  
reductions in mitochondrial oxidative enzymes and lineal density found within the  
skeletal muscles. Hepple et al. (40) showed a decreased V. O2max in aged individuals 
compared to that of young individuals receiving the same amount of bulk Q&  to the 
skeletal muscle. This is indicative of a reduced capacity to extract O2. Therefore, it is  
believed that alterations in the microcirculation produce a decrease extraction ability and  
cause decrements in V
.
O2max. 
Alterations in Microvasculature 
Reductions in a-vO2 found with aging might be related to alterations in the 
microcirculation and these alterations are primarily due to peripheral derangements (61). 
One of the greatest indications of an impaired microcirculatory system would be an 
impaired diffusing capacity of O2 (DO2) across the blood-myocyte barrier. Hence, if a 
low DO2 were present then extraction of O2 by skeletal muscle would be reduced and a 
lower exercise performance would transpire. This is evident when one analyzes the 
diffusion capacity equation solved for oxygen extraction [O2 extraction = 1 – e (-DO2/ßVRBC), 
where ß is the slope of the O2 dissociation curve]. In regard to diffusion capacity, aged 
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individuals have a higher capillary VRBC and FRBC then young individuals, which causes a 
decreased transit time for diffusion to occur in the muscle (74). The decrease in transit 
time allows for less time to offload O2 from the RBC putting a greater strain on the 
muscle. It has been hypothesized that reductions in both VRBC and FRBC occur during 
muscle contractions in aged individuals. However, experimental evidence supporting this 
notion has yet to be produced and needs to be the focus of future studies.  
Capillarization also appears to be disrupted in aging. The linear density of flowing 
capillaries is reduced with age (74) and this contributes to an increased VRBC and FRBC as 
stated above and potentially contributes to the decrease in a-vO2 difference in aged 
individuals when compared to young individuals. However, aged individuals demonstrate 
a maintained or improved capillary-fiber-interface, thus indicating microvascular 
functional derangements (41, 56). 
Blood Flow (Q& ) 
At the onset of contractions an increased Q& m is needed to meet the increased O2 
demand by the contracting muscle. The increase in Q& m is distinguished by three phases. 
The first of these phases is possibly due to the combination of a muscle pump effect and 
some degree of rapid vasodilation (82). Phase 1 normally lasts around 10-20 seconds. 
Phase 2 is illustrated by a continued increase in Q& m due to the increased vascular 
relaxation within the working muscle along with an increased vasoconstriction within the 
non-working muscles. Phase 3 occurs when the Q& m is able to meet the demand of the 
working muscle for a continuous period of time producing a steady state.  
In healthy young individuals, Q& m increases with the onset of contractions and is  
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sustained during the steady state (50, 51, 78).  This increase in Q& m is directly related to  
the oxidative metabolism found in muscle (V. O2m) (30, 70) and is directly related to 
exercise tolerance and capacity. In aged subjects Q& m has shown to be reduced 
significantly compared to young subjects causing a greater reliance on non-oxidative 
metabolism (36, 53, 66, 67).  This decreased Q& m is directly related to modification in the 
processes that cause the arteriolar vessels to dilate (60, 67).  
Although a majority of studies have shown that Q& m is decreased in aged 
individuals, Musch et al. (61) showed that bulk Q& m was maintained in aged in rats during 
submaximal exercise. Surprisingly, Musch et al. (61) also demonstrated a redistribution 
of Q& m from the muscles containing a majority of highly oxidative fibers to the muscles 
containing a majority of highly glycolytic fibers. The reduced Q& m to the SO fibers could 
potentially cause an earlier onset of fatigue via promoting the utilization of non-oxidative 
metabolism. Moreover, these results indicate that age-related changes may be occurring 
in the microcirculation.   
Role of Nitric Oxide 
The vascular tone in skeletal muscle is continuously changing between 
vasoconstriction and vasodilation depending on the demands. The modification of the 
vascular wall is of great importance to either increase or decrease Q& m. Thus, any 
alterations that cause impairment on the vascular tone could be detrimental. This control 
is of vital importance in terms of directing blood towards the working muscle where 
vasodilation must occur and reflecting blood away from the non-working muscle by 
means of vasoconstriction. Many plausible compounds (NO, EDHF, prostaglandins, 
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hydrogen peroxide, inorganic phosphate, etc) have been proposed for causing 
vasodilation allowing for an increased Q& m.  
Aged individuals demonstrate an impaired endothelial-mediated vasodilation in 
the working skeletal muscle. The major player in the reduced endothelial vasodilation is 
believed to be the reduced bioavailability of NO, which is believed to be a major 
contributor to the skeletal muscle hyperemia seen in healthy young individuals during 
exercise (43, 44, 77). NO is synthesized by NO synthase (NOS) which is present in three 
different types of isoforms; type I NOS (neural), type II NOS (inducible) and type III 
NOS (endothelial) (68). All three isoforms of NOS, in combination with L-arginine, 
produce NO. Certain compounds seem to indicate that NO plays a vital role in increasing 
Q& m to the exercising muscle. NG-nitro-L-arginine methyl easter (L-NAME) has shown 
to inhibit the bioavailability of NO (30). Administration of sodium nitro-prusside (SNP) 
has shown to increase the bioavailability of NO (30). Previous studies have shown that 
both L-NAME and SNP produce decreases and increases Q& m respectively. Therefore, it 
is believed that NO plays a vital role in the regulation of Q& m and the hyperaemic 
response to exercise. Thus, any dysfunction in the production of NO and/or regulation of 
vascular tone could impair the hyperaemic response to exercise with the eventually 
outcome being a worsening in an individual’s endurance capacity. 
Free Radicals and NO Bioavailability 
It has been shown that there is reduction in vascular NO available in aged 
individuals (12, 27, 28, 79, 80, 84), which may help explain the reduced Q& m response to 
muscle contractions (61, 67).  This decrease in NO bioavailability may be explained by 
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the increasing leakage of reactive oxygen species (ROS) from the mitochondria in aged 
individuals (27, 35, 80). ROS are a naturally occurring byproduct of oxidative 
metabolism that leak from the mitochondria.  In young healthy individuals, leaked ROS 
account for about 2-3% of mitochondrial oxygen consumption (69). In aged individuals, 
generation and leakage of ROS are accelerated compared to their young counterparts. 
The most common leaked ROS is superoxide (O2-) anion, which can undergo electron 
exchange producing hydrogen peroxide (H2O2) and a hydroxyl radical. All can cause 
detrimental effects to the cell.  
ROS do not always have a negative effect. H2O2 can play a vital role in producing 
vasodilation in skeletal muscle (19). The increased production of ROS is not the only side 
effect of aging. Aged individuals also appear to have a decreased antioxidant defense 
system against these free radicals. This imbalance between the increased O2- generation 
and reduced antioxidant defense system disrupts cellular function and Reid et al. (69) 
found that with aged individuals this imbalance between ROS and antioxidant defense 
systems could significantly affect muscle force production. 
ROS can influence NO bioavailability in two ways. First, it scavenges NO to 
produce peroxynitrite. Second, it decreases the concentration of a co-factor, 
tetrahydrobiopterin, which is essential for the production of NO by NOS (38, 39). NO 
and ROS compete for the same binding areas located on proteins, which could reduce the 
ability of NO to produce vasodilation (68). An increase in ROS production can also occur 
when a reduced availability of L-arginine is present causing NOS to produce O2- instead 
of NO (68). Although ROS (i.e., H2O2) play a role in vasodilation it pales in comparison 
to the vital importance of NO. The increased ROS production causing a lowered NO 
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bioavailability along with a reduced antioxidant defense system could produce significant 
decrements in skeletal muscle vasodilation via reductions in NO bioavailability.  
Partial Pressure of Oxygen (PO2mv) 
Q& m and V
.
O2m are of vital importance because they are the primary factors that 
determine the partial pressure of oxygen in the muscle microvasculature (PO2mv). In the  
muscle, PO2mv is proportional to the ratio of oxygen delivery ( Q& O2m) and the muscle’s  
metabolic rate (V. O2m) ( Q& O2m/V
.
O2m).  Increases in Q& m are imperative to provide an 
adequate driving pressure for O2 to transfer from the capillary to the myocyte during the  
rest-to-contraction period (65, 85) and after reaching the steady state (7, 8, 31).  
In normal young individuals Q& m and Q& O2m increase at a faster rate than V
.
O2m, 
which produces a slower decrease in PO2mv (Q& O2m/V
.
O2m) when compared to aged  
 
individuals or individuals with disease (i.e., CHF, diabetes) (9-11). The biphasic increase  
in Q& m at the onset of contractions coupled with the monoexponential increase in V
.
O2m  
produces a brief steady state (10-20 sec) in the Q& O2m/V
.
O2m ratio, which is referred to as 
the time delay (TD). Following the TD the PO2mv begins to fall in a monoexponetial 
manner. However, if the rate of Q& O2m during the transition phase from rest to the steady 
state of exercise is slowed, it leads to a more rapid decrease in PO2mv (8, 24, 31).  This 
slowed Q& O2m response has been shown to occur in aged individuals primarily and has  
been primarily ascribed to a diminished bioavailability of NO. Moreover, this slowed  
Q& O2m response is believed to produce a temporal mismatch between the Q& O2m/V
.
O2m 
ratio during the rest-to-steady state contractions producing an “undershoot” of the PO2mv  
response. Eventually, the slowed Q& O2m found in aged individuals is able to meet to the   
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V
.
O2m by the working muscle and upon equilibration, the PO2mv comes to a continual 
steady state. However, this altered PO2mv profile found in the aged individuals could  
produce a lower driving pressure across the intravascular muscle interface, during the  
transition from rest to muscle contractions which could slow V
.
O2 kinetics, increase O2 
deficit (26) and increase mitochondrial ROS production (16). 
Antioxidant Supplementation 
A very plausible way to increase an individuals antioxidant defense system would 
be through antioxidant supplementation. Antioxidants work by scavenging free radicals. 
Thus, antioxidant supplementation should decrease the amount of circulating ROS and 
could either partially or fully restore endothelial-mediated vasodilation function of aged 
individuals (27, 79). In this regard, an antioxidant that could mimic superoxide dismutase 
(SOD) (which reacts readily with O2-) along with an antioxidant that acts like catalase (to 
produce water and O2 from H2O2) may restore endothelial vasodilation by reducing the 
amount of circulating ROS and increasing the bioavailability of NO. Two compounds 
that are able to work in this fashion are tempol and ascorbic acid (vitamin C).  
Tempol is a compound that mimics the enzyme SOD. It readily reacts with O2- 
producing H2O2 and is able to mimic all three types of SOD isoforms which are 1) SOD1 
(CuZnSOD); 2) SOD2 (MnSOD); 3) SOD3 (ECSOD). Each type of SOD isoform is 
located in different anatomical compartments. SOD1 is located in the cytoplasm, SOD2 is 
positioned in the mitochondria and SOD3 is situated in the extracellular space. Therefore, 
the infusion of tempol should produce antioxidant effects in all 3 of these anatomical 
locations and because of its ability to bind with O2- it should potentially produce drastic 
  16 
increases in the bioavailability of NO. Consistent with this hypothesis, tempol has been 
shown lower (i.e., normalize) blood pressure after infusion in hypertensive rats (76).  
Ascorbic acid is able to scavenge ROS and increase the concentration of NO. 
Ascorbic acid mimics the enzyme catalase by producing H2O and O2 from H2O2. 
Ascorbic acid improves endothelial function by also stabilizing tetrahydrobiopterin (37) 
and alpha-tocopherol (38), which are cofactors for the production of NO. Without the 
production of these cofactors, the production of NO would be reduced. Thus, ascorbic 
acid has the potential to increase vasodilation through different mechanisms making it a 
very appealing for therapeutic use.  
Antioxidant supplementation can have negative effects as well as positive effects. 
If antioxidant supplementation works as described previously then the bioavailability of 
NO should increase. However, if the bioavailability of NO increases above a certain 
concentrations it begins to have detrimental effects. In this regard, previous studies have 
shown that a high bioavailability of NO will reversibly inhibit mitochondrial respiration 
by competing with O2 for the same binding site within the electron transport chain (17). 
In addition, a high bioavailability of NO has been shown to decrease muscle force 
production (68). 
Summary 
Aged individuals demonstrate significant reductions in exercise tolerance and 
capacity when compared to their younger counterparts. The factors contributing to these 
reductions in exercise tolerance and capacity appear multifactorial and related to changes 
in both intra-cellular and extra-cellular function. However, the maintenance of O2 
delivery ( Q& m) along with the PO2mv from the intravascular space to the mitochondria 
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appears critical during the transition from rest-to-exercise and these contributions of both 
conductive and diffusive O2 delivery are significantly reduced in aged individuals. 
One of the factors contributing to these decrements in O2 delivery appears to be 
associated with age-related reductions in NO bioavailability. Moreover, the age-related 
reductions in NO bioavailability appear to be associated with increases in the generation 
of ROS along with reductions in antioxidant defense mechanisms found in the muscle of 
these individuals.  
Whether or not antioxidant supplementation would be beneficial in aged 
individuals remains unclear this time. However, based on previous studies it appears 
plausible that antioxidant supplementation (whether acute or chronic) would prove to be 
extremely beneficial. In this regard, antioxidant supplementation could significantly 
reduce ROS and increase NO bioavailability. The increased NO bioavailability could 
hypothetically increase both Q& m and PO2mv during the transition from rest-to-exercise, 
thereby reversing the age-related deficits found in these individuals. The consequence of 
maintaining or enhancing Q& m and PO2mv would be the amelioration of age-related  
deficits in both conductive and diffusive O2 delivery, the normalization of both PO2mv and  
V
.
O2m profiles during the transition from rest-to-exercise (muscle contractions), along 
with potential increases in both exercise tolerance and capacity. The end result being an 
increase in the quality of life for these individuals.  
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CHAPTER 3 - Methods 
Animals 
Twenty old (26-30 months, body mass 563 ± 19 g) male Fisher 344x Brown 
Norway hybrid rats were used in this investigation and were kept completely sedentary.  
Rats were maintained on a 12:12-h light: dark cycle and received water and food ab 
libitum. Upon completion of the experiment, each rat was killed with pentobarbital 
sodium overdose. All protocols were approved by the Kansas State University 
Institutional Animal Care and Use Committee (IACUC), conformed with guiding 
principles of the American Physiological Society and were conducted according to the 
National Institutes of Health Guidelines. 
Surgical Preparation 
All rats were anaesthetized with pentobarbital sodium (50 mg kg -1 i.p., to effect) 
and placed on a heating pad to maintain a constant body temperature of 37-38◦C. The 
carotid and tail (caudal) arteries were cannulated (Polyethylene-50, Intra-Medic tubing; 
Clay Adams, Sparks, MD, USA) for infusion of the phosphorescent probe palladium 
meso-tetra (4-carboxyphenyl) porphyrin dendrimer (R2; 15 mg kg -1), monitoring of 
arterial blood pressure and heart rate (Digi-Med BPA model 200, Louisville, KY, USA) 
and blood withdrawal. Catheter placement also permitted the measurement of resting and 
contracting muscle blood flow ( Q& m) using the radiolabeled microsphere technique (52, 
62).  
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Skin and fascia around the mid-dorsal region of the rat was reflected back to 
expose the right spinotrapezius muscle. Stainless steel electrodes were sutured to the 
rostral (cathode) and caudal (anode) region of the spinotrapezius using 6-0 sutures to 
ensure that electrode position remained unchanged throughout the experimental 
protocols.  
Measurement of Microvascular PO2 
PO2mv measurements were made using a PMOD 1000 Frequency Domain 
Phosphorimeter (Oxygen Enterprises, Ltd., Philadelphia, PA). After exposure of the right 
spinotrapezius, the common end of the bifurcated light guide was placed 2-3 mm above 
the medial region of the muscle and excitation light focused on a ~ 2 mm-diameter circle. 
The phosphorescence quenching technique for measurement of PO2mv is based upon the 
Stern-Volmer relationship (73), which describes the O2 dependence of phosphorescence 
decay in the presence of the phosphorescence probe. The phosphorescence signal (700 
nm) was averaged over 10 x 200 ms intervals for all PO2mv measurements and these 
measurements were repeated every 2 s. The phosphorometer utilizes a sinusoidal 
modulation of the excitation light (524 nm) at frequencies between 100 Hz and 20 kHz, 
which allows phosphorescence lifetime measurements from 10 µs to approximately 2.5 
ms.  
Measurement of Spinotrapezius Blood Flow 
Spinotrapezius Q& m was determined using the radionuclide-tagged microsphere 
technique as described in detail by Musch and Terrell (62). The caudal artery catheter 
was attached to a Harvard pump (model 907, Cambridge, MA) for blood withdrawal at 
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0.25 ml min-1. Two differentially-labeled 15 µm microspheres (46Sc, 85Sr) (New England 
Nuclear, Boston MA) were injected through the carotid artery and the catheter flushed 
with saline. In random order and during steady-state contractions, one isotope was 
injected under control conditions and the second isotope after antioxidant 
supplementation. At the end of each experiment, the animal was euthanized and both 
right and left spinotrapezius muscles along with the right and left kidneys removed. 
Tissue radioactivity was determined by a gamma scintillation counter (Packard Auto 
Gamma Spectrometer, Cobra Model 5003) and Q& m were determined by the reference 
sample method as described by Ishise et al. (48).  
Measurement of PO2mv Dynamics 
The R2 probe was infused via the right carotid artery catheter approximately 15 
minutes before the first contraction period. The spinotrapezius was kept moist 
continuously with Krebs-Henseleit solution. After measuring PO2mv in the resting state, 
the spinotrapezius was stimulated at 1 Hz for 180 seconds (7-9 volts, 2 ms pulse duration) 
using a Grass S88 stimulator (Quincy, MA, USA). During contractions of the right 
spinotrapezius the non-exposed contralateral (left) spinotrapezius was maintained in a 
resting (non-contracting) state. Continual measurements of PO2mv were made in the right 
spinotrapezius and recorded every 2 seconds during the 180-second contraction period. 
Following the initial contraction period, each animal was given a minimum of 50 minutes 
for the right spinotrapezius muscle to recover. During this recovery period, animals were 
infused with either saline or a solution containing the antioxidants (ascorbic acid: 7.6 
mg/100g and tempol: 300 mmol/kg; dissolved in 1.5 ml saline) and the original 
contraction protocol was repeated. The dosage of ascorbic acid utilized herein has 
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demonstrated beneficial effects in diseased states (i.e., sepsis) by reducing that amount of 
circulating ROS (2, 83). Our concentration of tempol used in the present investigation has 
exhibited beneficial cardiovascular effects (87). 
Measurement of Spinotrapezius Force Production 
In a separate group of aged rats (n = 4), the distal end of the right spinotrapezius 
was ligated and sutured to a stainless-steel wire horseshoe and attached to a non-
distensible light weight (0.4 g) cable linking the muscle to a force transducer. Baseline 
measurements were made with the spinotrapezius muscle stretched to Lo (length where 
maximum active tension is reached), which was obtained at ~ 4g passive tension. Muscle 
force production was measured and recorded continuously at rest and during contractions 
following the same procedure as those described above for Q& m and PO2mv.  
Calculations 
Curve fitting 
The dynamics of PO2mv were described by means of a non-linear regression 
analysis using a commercial software package (SIGMAPLOT 7.0I; Systat Software, 
Point Richmond, CA, USA). Curve fitting of the PO2mv results i.e., selection of 1 vs. 2 
component models were determined according to three criteria: 1) the coefficient of 
determination (r2), 2) the sum of the squared residuals, and 3) visual inspection. The 
equations used to fit the PO2mv kinetics are shown below.  
One Component: PO2mv (t) = PO2mv (BL) + ∆PO2mv (1 – e-(t-TD1)/τ)) 
Two Component: PO2mv (t) = PO2mv (BL) +  ∆1PO2mv (1 – e-(t-TD1)/τ1)) + ∆2PO2mv (1 – e-(t-TD2)/τ2)) 
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Baseline (BL) corresponds to pre-contraction PO2mv and ∆2PO2mv is the amplitude 
of the PO2mv response. Time constants were designated as τ1 and τ2 and TD1 and TD2 and 
were the independent time delays of the respective responses. When the response profile 
closely approximated a monoexponential only the primary component was used to fit the 
data. The two-component model was used whenever an “undershoot” was evident and the 
criteria listed above mitigated the more complex model. 
Oxygen Consumption 
V
.
O2m was estimated as previously described (8, 58). Arterial O2 content (CaO2) 
was measured directly (carotid arterial blood) and effluent venous O2 content (CvO2) was 
approximated from the PO2mv using the rat dissociation curve (“n” = 2.6 (Hill 
coefficient)), the measured hemoglobin concentration ([Hb]), P50 of 38 mmHg and an O2 
carrying capacity of 1.34 ml O2 g Hb-1) (58). Steady-state measurements of  
spinotrapezius blood flow made at rest and during muscle contractions were then used to  
calculate V
.
O2 using the Fick Equation [i.e. V
.
O2 = Q&  x (CaO2 – CvO2)].   
Stability and Reproducibility of the Spinotrapezius Preparation 
We have shown previously in our laboratory that the isolated spinotrapezius 
muscle preparation is physiologically stable and viable following the completion of this 
surgery (4). In addition, we have shown previously with the spinotrapezius preparation 
that we can retain reproducible PO2mv results during the transition from rest to muscle 
contractions when a minimum of 20 minutes of recovery is allowed between exercise 
bouts (B.J. Behnke, P. McDonough, T.I. Musch, D.C. Poole, unpublished findings). We 
re-affirmed the stability and reproducibility of the spinotrapezius preparation in the 
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present investigation by examining the PO2mv kinetics in 16 animals using the initial and 
subsequent contraction paradigm. Results demonstrated that reproducibility from the 
initial to the second contraction bout was excellent. Specifically, there was no change 
qualitatively in the PO2mv profile nor quantitatively (P>0.05) in any of the variables or 
parameters measured.  
Statistical Analysis 
The effects of the antioxidant supplementation on PO2mv, Q& m and force 
production were analyzed by Student t-tests and force production was also analyzed by a 
repeated ANOVA. Statistical significance was accepted at P < 0.05 and data are reported 
as mean ± SEM. 
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CHAPTER 4 - Results 
Microvascular Partial Pressure of Oxygen (PO2mv) 
Similar to previous findings in our laboratory (9), the aged rats demonstrated a 
biphasic PO2mv profile during the transition from rest to steady state contractions that 
consisted of a significant undershoot followed by a rise in the PO2mv to the steady-state 
level (Figure 4-1).  Moreover, these findings were similar to our control rats that received 
saline instead of antioxidant supplementation. Following the infusion of antioxidants  
PO2mv at rest increased significantly from 30.6 ± 0.9 to 35.7 ± 0.8 mmHg (P<0.05, Figure 
4-1, Table 4-1). Moreover, the PO2mv profile found following the onset of contractions 
was changed significantly as the “undershoot” found in the control condition was either 
greatly reduced or eliminated (Figure 4-1 & 4-2, Table 4-1). Consequently, after 
antioxidant supplementation, the PO2mv rest-to-contractions profile resembled closely that 
found previously in young animals (Figure 4-1, Table 4-1; (9)). The infusion of 
antioxidants also changed the magnitude of the PO2mv response as the reduction in PO2mv 
from rest to steady-state contractions increased from 13.8 ± 1.1 to 18.8 ± 1.1 mmHg 
(P<0.01, Table 4-1). This increase in the magnitude of the PO2mv response was primarily 
due to the increase in PO2mv found at rest following the infusion of antioxidants (Figure 
4-1, Table 4-1) as the PO2mv measured during steady-state contractions was not different 
following supplementation (19.7 ± 1.2 vs. 17.7 ± 1.0 mmHg, P>0.05, Table 4-1). 
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Muscle Blood Flow (Q& m) and Conductance 
Since PO2mv is dependent on the relationship of Q& O2m to V
.
O2m changes in Q& m 
exert a commanding influence on PO2mv during the transition from rest to muscle 
contractions. Q& m measured in the resting left spinotrapezius muscle was not significantly 
altered following antioxidant supplementation (Figure 4-3). In contrast, Q& m in the 
contracting right spinotrapezius muscle decreased significantly (42%) following the 
infusion of antioxidants. Antioxidant supplementation affected the resting hindlimb 
locomotor Q& m somewhat differently however. Specifically, at rest Q& m was either 
increased (i.e., soleus) or tended to increase following antioxidant supplementation 
(Table 4-2). 
Antioxidant supplementation lowered mean arterial pressure (MAP) significantly 
from 131 ± 5 to 107 ± 4 mmHg (P<0.05), respectively. When spinotrapezius Q& m was 
normalized to MAP and expressed as conductance, antioxidant supplementation had no 
significant effect on conductance (Table 4-3). In contrast, for the hindlimb locomotor 
muscles vascular conductance was substantially elevated following the infusion of 
antioxidants (Table 4-3).  
Oxygen Consumption (V. O2m) 
Since PO2mv is dependent on the Q& O2m to V
.
O2m relationship, alterations in V
.
O2m  
could also have significant effects on PO2mv during the rest-to-contraction transition.  
  26 
Antioxidant supplementation had no significant effect on the V
.
O2m estimated for the 
spinotrapezius muscle at rest (Figure 4-5). Although antioxidant supplementation had no 
significant effect in the arterial O2 content (CaO2), we found that the infusion of 
antioxidants produced a significant increase in the venous O2 content (CvO2) estimated 
from PO2mv. This resulted in a significant decrease in the a-vO2 diff following antioxidant  
supplementation (Table 4-4) but due to inter-animal variability this was not associated  
with any significant changes in the resting V
.
O2m (Table 4-4).  
Following antioxidant supplementation there was a trend for V
.
O2m to be reduced  
during steady state contractions (P = 0.13). This antioxidant-induced trend towards a  
decreased V
.
O2m was associated with a reduction in Q& m in the absence of significant 
alterations in CaO2, CvO2, or a-vO2 diff (Table 4-4).  
Muscle Force Production: 
Because antioxidant supplementation reduced Q& m significantly and tended to  
decrease V
.
O2m it was important to determine the effects of antioxidant supplementation 
on muscle force production.  Antioxidant supplementation produced a significant 
decrease in the amount of force that was generated in the contracting right spinotrapezius 
muscle during a constant voltage stimulus. Force generation was reduced 16.5% within 
the first contraction and remained depressed throughout the subsequent four-minute  
contraction period (Figure 4-6). The ratio of the right contracting spinotrapezius muscle  
force production to V
.
O2m demonstrated a significant increase (0.92 ± 0.03, 1.06 ± 0.6, 
respectively, P<0.05) after antioxidant supplementation. 
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Table 4-1: Partial Pressure of Oxygen  
 Before Antioxidant 
Supplementation 
After Antioxidant 
Supplementation 
PO2mv resting baseline 
(mmHg) 
30.6 ± 0.9 35.7 ± 0.8 ** 
PO2mv nadir – exercise 
(mmHg) 
16.8 ± 1.2 16.9 ± 1.0 
PO2mv exercise steady state 
(mmHg) 
19.7 ± 1.2 17.7 ± 1.0 
PO2mv ‘undershoot’ (steady 
state – nadir) (mmHg) 
2.8 ± 0.7 0.8 ± 0.4 * 
PO2mv (rest-nadir) amplitude 
(mmHg) 
13.8 ± 1.1 18.8 ± 1.1 ** 
TD (s) 8.5 ± 0.6 8.8 ± 0.6 
tau (s) 14.3 ± 2.5 17.1 ± 2.1 
Microvascular PO2 (PO2mv) values and model parameters measured at rest and during 
contractions in the right spinotrapezius muscle. Values are means ± SEM. * P < 0.05 
vs. pre-infusion and ** P < 0.01 vs. pre-infusion. TD = the time from the onset of 
initial onset of contractions to initial in decrease in the PO2mv profile, tau = the time it 
takes for 63% of the initial component to occur. 
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Table 4-2: Blood Flow 
 Before Antioxidant 
Supplementation 
After Antioxidant 
Supplementation 
Right Muscles   
Soleus 11 ± 2 26 ± 5 ** 
Plantaris 7 ± 1 15 ± 4 
Red Gastrocnemius 11 ± 3 20 ± 5 
White 
Gastrocnemius 
9 ± 2 13 ± 2 
Mixed 
Gastrocnemius 
7 ± 1 8 ± 2 
Extensor Digitorum 
Longus 
7 ± 1 12 ± 4 
Left Muscles   
Soleus 9 ± 2 16 ± 6 
Plantaris 8 ± 1 10 ± 3 
Red Gastrocnemius 14 ± 3 24 ± 6 
White 
Gastrocnemius 
8 ± 2 12 ± 2 
Mixed 
Gastrocnemius 
6 ± 1 8 ± 2 
Extensor Digitorum 
Longus 
9 ± 1 15 ± 5 
Blood Flow ( Q& m) measured at rest in various hindlimb locomotor muscles. Values are 
means ± SEM in ml min-1100g-1. ** P < 0.01 vs. pre-infusion  
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Table 4-3: Conductance 
 Before Antioxidant 
Supplementation 
After Antioxidant 
Supplementation 
Right Muscles   
Soleus 0.08 ± 0.01 0.25 ± 0.05 ** 
Plantaris 0.06 ± 0.01 0.14 ± 0.04 * 
Red Gastrocnemius 0.09 ± 0.03 0.20 ± 0.05 * 
White 
Gastrocnemius 
0.07 ± 0.01 0.12 ± 0.02 * 
Mixed 
Gastrocnemius 
0.06 ± 0.01 0.07 ± 0.02 
Extensor Digitorum 
Longus 
0.05 ± 0.01 0.12 ± 0.04 
Spinotrapezius 1.22 ± 0.23 0.76 ± 0.16 
Left Muscles   
Soleus 0.07 ± 0.01 0.15 ± 0.05 
Plantaris 0.06 ± 0.01 0.10 ± 0.03 
Red Gastrocnemius 0.11 ± 0.02 0.23 ± 0.06 * 
White 
Gastrocnemius 
0.06 ± 0.02 0.11 ± 0.03 
Mixed 
Gastrocnemius 
0.05 ± 0.01 0.07 ± 0.02 
Extensor Digitorum 
Longus 
0.07 ± 0.01 0.15 ± 0.05 
Spinotrapezius 0.10 ± 0.02 0.11 ± 0.03 
Resting conductance of selected hindlimb locomotor and spinotrapezius muscle when 
muscle blood flows were normalized to MAP. Values are means ± SEM in ml min-
1100g-1mmHg-1. * P < 0.05 vs. pre-infusion and ** P < 0.01 vs. pre-infusion 
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Table 4-4: Oxygen Consumption 
 Before Antioxidant 
Supplementation 
After Antioxidant 
Supplementation 
Contracting (Right) 
Spinotrapezius 
  
Estimated PvO2 
(mmHg) 
19.8 ± 1.4 18.3 ± 1.1 
SvO2  0.16 ± 0.02 0.13 ± 0.02 
CvO2 (ml/dl) 3.0 ± 0.4 2.5 ± 0.3 
a-vO2 diff (ml/dl)‡ 14.5 ± 0.5 15.0 ± 0.5 
V
.
O2 (ml min-1100g-1) 
19.7 ± 3.2 14.5 ± 2.9 
Resting (Left) Spinotrapezius 
  
PvO2 (mmHg) 30.0 ± 0.1 36.0 ± 0.9 ** 
SvO2  0.35 ± 0.02 0.463 ± 0.02 ** 
CvO2 (ml/dl) 6.3 ± 0.4 8.4 ± 0.4 ** 
a-vO2 diff (ml/dl) ‡ 11.2 ± 0.4 9.1 ± 0.4 ** 
V
.
O2 (ml min-1100g-1) 
1.6 ± 0.4 1.3 ± 0.3 
Oxygen transport variables calculated for the right contracting spinotrapezius and left 
resting spinotrapezius muscle. Values are means ± SEM. ** P < 0.01 vs. pre-infusion. 
‡The mean values for arterial partial pressure of oxygen in the blood (PaO2 = 88.6 ± 4.8 
mmHg), arterial oxygen saturation (SaO2 = 97 ± 1%), hemoglobin concentration (Hb = 
13.3 ± 0.3 g 100ml-1), and arterial oxygen content (CaO2 = 17.5 ± 0.5 ml 100ml-1) 
remained unchanged after antioxidant supplementation.  
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Figure 4-1: PO2mv versus Time 
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Time course of change in spinotrapezius O2 partial pressure (PO2mv) following the onset 
of contractions (vertical line at 0 s) measured before (dashed line) and after antioxidant 
supplementation (solid line) for a representative animal. Note the pronounced 
‘undershoot’ of PO2mv that drives PO2mv below the subsequent end-contraction values. 
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Figure 4-2: PO2mv ‘undershoot’ 
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Effect of antioxidant supplementation on the ‘undershoot’ (see Figure 1 for a visual 
represenitive of ‘undershoot’) of microvascular O2 partial pressure (PO2mv) in 
spinotrapezius muscle (n = 16). Note that in nearly all cases the “undershoot” decreased 
towards, or became, zero. Animals that illustrated the same response after antioxidant 
supplementation are illustrated by one line.  * Before vs. after supplementation (P < 
0.05). 
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Figure 4-3: Blood Flow versus Time 
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Blood flow (ml min-1 100g-1) to the resting and contracting spinotrapezius muscles  
measured before (closed box) and after (open box) antioxidant supplementation (n = 7). 
Data are means ± SEM. * Before vs. after supplementation (P<0.05).
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Figure 4-4: Conductance versus Time 
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Conductance (ml min-1 100g-1 mmHg-1) to the resting and contracting spinotrapezius 
muscle before (closed box) and after (open box) antioxidant supplementation (n = 7). 
Data are means ± SEM. 
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Figure 4-5: Oxygen Consumption versus Time 
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V
.
O2m (ml min-1 100g-1) to the resting and contracting spinotrapezius muscles before 
(closed box) and after (open box) antioxidant supplementation (n = 6). Data are means ± 
SEM. 
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Figure 4-6: Muscle Force Production versus Time 
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Muscle force production generated by the contracting right spinotrapezius muscle before 
(closed circles) and after antioxidant supplementation (open circles) (n = 4). Data are 
means ± SEM. * Before vs. after supplementation (P<0.05). 
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CHAPTER 5 - Discussion 
To our knowledge, the present investigation was the first to examine the effects of 
antioxidants (tempol and ascorbic acid) on the PO2mv kinetics in contracting muscle of 
aged rats. The principal novel findings of our investigation were that following  
antioxidant supplementation: 1) the baseline PO2mv in the resting spinotrapezius muscle  
was significantly increased, but Q& m remained unchanged; 2) the temporal Q& O2m/V
.
O2m 
mismatch (i.e., PO2mv undershoot) found following the onset of contractions during the 
transition from rest-to-contractions was significantly decreased, but Q& m during steady-
state contractions was significantly reduced; 3) muscle force production during 
contraction was significantly impaired; and 4) saline and before infusion of antioxidants 
demonstrated similar results therefore illustrating the effects witnessed in this study were 
due to the infusion of antioxidants.  
Effects of Antioxidants on PO2mv, Q& m and Conductance at rest  
The resting baseline PO2mv found in the spinotrapezius was significantly increased 
following antioxidant supplementation. This elevation in PO2mv was hypothesized to 
result from elevation of Q& m and vascular conductance consequent to a decrease in ROS 
concentration and an increased NO bioavailability. However, Q& m and spinotrapezius 
conductance remained either unchanged or even decreased slightly in contrast to select 
locomotor muscles (Tables 4-2 & 4-3). Therefore, with respect to the primary muscle of 
interest, the spinotrapezius, the present results do not support our original hypothesis 
number two.  
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Skeletal muscles vary in their fiber type composition and function. In this regard, 
the spinotrapezius muscle contains all of the basic fiber types [41% type I, 7% type IIa, 
35% type IIb, and 17% IId/x] found in rats (22), while other muscles may only contain 
two or three of these predominant fiber types. For example, in the rat, the soleus contains 
primarily type I fibers ~ 84%, (22),  while other locomotor muscles from the hindlimb 
contain a variety of fiber types ranging widely in their distribution. We found increases in 
resting Q& m and conductance in several different hindlimb locomotor muscles following 
antioxidant supplementation (Table 4-2 & 4-3) in a manner that did not appear to be 
fiber-type dependent. In marked contrast, resting Q& m and conductance remained 
unchanged or even decreased slightly in the spinotrapezius muscle following the infusion 
of antioxidants. The mechanisms responsible for these changes or lack of changes in 
resting Q& m and conductance found after antioxidant supplementation are unclear at this 
time. However, sympathetic activation and/or withdrawal have a commanding effect on 
Q& m and conductance (42) and the possibility exists that muscle specific changes in 
sympathetic vascular tone might have resulted from infusion of antioxidants and thus 
have contributed to the present results. 
The present investigation demonstrated clearly that antioxidant supplementation 
produced an increase in the resting PO2mv of the spinotrapezius muscle without any  
significant changes in resting Q& m or conductance to the muscle which implies that the  
resting metabolic rate (V. O2m) must have decreased. Indeed, there was an absolute V
.
O2m 
fall of ~ 10% in the resting spinotrapezius. However, inter-animal variability appears to 
have been responsible for the statistical inability to detect this difference at the P<0.05 
level. 
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Effects of Antioxidants on the transition of PO2mv from rest to exercise: 
There are three distinct phases during the transition from rest to exercise in the 
PO2mv profile that have been described previously for the spinotrapezius muscle in young 
rats (11). There is an initial time delay (TD) at the initial onset of contractions where the 
PO2mv profile either remains constant (lasting around ~ 10-20 seconds) or increases  
slightly. This has been interpreted as Q& O2m increasing sufficiently to meet the rising       
V
.
O2m demands (11).  
In the present investigation the TD before antioxidant supplementation was 
consistent with that demonstrated previously in aged rats (9).  We expected initially that 
that the antioxidant supplementation would produce an increase in the TD due to an 
increased bioavailability of NO thereby allowing an increased NO-mediated vasodilation. 
However, we were surprised to find that the TD was unaffected by antioxidant  
supplementation (Figure 4-1, Table 4-1) and we attributed this finding to a preservation  
of the Q& O2m/V
.
O2m ratio albeit at different absolute levels of Q& O2m and V
.
O2m.  
In young, healthy animals after the onset of contractions subsequent to the TD the  
PO2mv profile is described by an exponential decrease in the PO2mv (Figure 1). This  
dynamic phase represents an interval when V
.
O2m is still increasing and doing so out of 
proportion to Q& O2m  until the steady-state is reached (9, 11). Our laboratory has 
demonstrated that disease states such as chronic heart failure (24) and diabetes (10), as  
well as aged individuals (9) express a biphasic post-TD response that is characterized by  
an “undershoot” or a temporal mismatch between Q& O2m and V
.
O2m that is subsequently 
rectified, presumably as Q& O2m increases later in the contraction bout (i.e., the Q& O2m 
response is sluggish). The occurrence of this “undershoot” in aged individuals in the 
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present investigation is consistent with those previous findings (Figures 4-1 and 4-2). 
Before the infusion of antioxidants all of the aged rats (i.e., 16 of 16) demonstrated an 
“undershoot” in the present investigation, which was qualitatively and quantitatively 
similar to those found previously (9, 10, 24). This “inadequate” Q& O2m response may 
occur consequent to an impaired NO-mediated vasodilation.  
Thus, following the TD, the overall PO2mv was reduced significantly in aged rats 
when compared to their younger counterparts (9). These reductions in PO2mv represent a 
decreased O2 driving pressure from the muscle microvascular space to the mitochondria 
during the transition from rest-to-contractions. Previous studies support the idea that there 
is less NO bioavailability during muscle contractions (i.e., exercise) when aged 
individuals are compared to their younger counterparts and it is believed that this 
decreased NO may be mechanistically related to the diminished Q& m response found in 
these individuals (12, 27, 28, 79, 80, 84). It should be noted that previous studies have not 
examined the effects of antioxidants on the PO2mv profile. We originally anticipated that 
infusion of antioxidants would increase the bioavailability of NO thereby amplifying the 
vasodilatory response found in the contracting muscle. Contrary to our expectations, we 
found that spinotrapezius Q& m was actually reduced which was not consistent with 
hypothesis number three.  
The PO2mv profile reaches a steady-state > 60 seconds after the onset of  
contractions and this condition is believed to constitute attainment of steady-state levels  
of both Q& O2m and V
.
O2m. Our findings indicate that antioxidant supplementation had no 
significant effect on the contracting steady-state PO2mv. However, due to the increased 
resting PO2mv found after antioxidant supplementation and the reduced contracting Q& m 
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there was a significant increase in the amplitude of the ∆PO2mv response (Figure 4-1, 
Table 4-1).  
Other Potential Mediators of the PO2mv Profile 
Previous studies support the notion that endothelium-mediated vasodilation is 
reduced in aged skeletal muscle and that this reduction can be ascribed, in part, to an 
increase in ROS found in this population (27, 35, 80). The primary source of increased 
ROS during exercise is thought to be skeletal muscle mitochondria where ROS are 
generated between complex I and complex III of the electron transport chain (ETC) 
during oxidative phosphorylation (13, 49). Contrary to our expectations following  
antioxidant supplementation, we found that Q& m (and therefore Q& O2m) was significantly  
decreased during steady-state contractions. Moreover, we found that the calculated V
.
O2m 
was also reduced, contrary to the anticipated beneficial effects on the ETC. Given these 
findings the likelihood that increased NO bioavailability may have competitively 
inhibited the binding of O2 in the ETC must be considered (17). Although the infusion of 
antioxidants may have reduced ROS in the contracting muscle and thereby increased the  
bioavailability of NO, in turn this increased [NO] may have compromised mitochondrial  
function and hence V
.
O2m. Since the Q& m response found in skeletal muscle is tightly  
coupled to oxidative metabolism (i.e., V. O2m) under exercising (contracting) steady-state 
conditions (23), the probability exists that any potential increase in vasodilatory function  
was effectively offset by reductions in oxidative metabolism (Table 4-4, Figure 4-5) with  
the net effect that both Q& m (Q& O2m) and V
.
O2m were reduced.  
There also may have been direct effects of NO on skeletal muscle contractile  
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function which, in addition to decreased V
.
O2m, may have impaired muscle force 
production. Accordingly, previous studies have shown that high concentrations of NO 
can significantly inhibit muscle force production (68, 69). The mechanistic factors 
associated with this observation are not fully understood at this time, but Reid and 
colleagues (69) have suggested that muscle-derived ROS and NO can modulate force 
production via the redox status of the muscle. This relationship has been schematized as a 
bell-shaped process (Figure 5-1). According to Reid and colleagues (69) in contrast to the 
young healthy individual whose redox state places them just to the left of the optimal 
muscle force production on the bell curve their aged counterparts might be placed to the 
right of optimal muscle force production due to elevated concentrations of ROS which 
has increased their oxidized state (69). It was our belief that antioxidant supplementation 
would shift the redox state in aged individuals such their muscle biochemical 
environment would be closer to that which would normally be found in younger 
individuals (i.e., closer to optimal/maximal muscle force production). Contrary to our 
original belief, antioxidant supplementation significantly reduced muscle force 
production. Due to the effect of antioxidants on ROS it is likely our protocol actually 
produced a larger-than-anticipated swing towards the reduced state-one consequence of  
which was reduced muscle force production (Figure 5-1). This effect is likely to be  
coupled to the lowered V
.
O2m after the infusion of antioxidants. Therefore, the contracting  
spinotrapezius muscle produced less force at a lower energy (V. O2m) cost. In support of  
this hypothesis we found that the ratio between force production and V
.
O2m actually  
increased ~ 15% which means that the contracting spinotrapezius muscle was able to  
increase its force production per unit of V
.
O2m (i.e., contracting more efficiently) after 
antioxidant supplementation. This process may have facilitated the improved temporal 
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Q& O2m/V
.
O2m ratio during the transition from rest-to-exercise and is consistent with the 
elevated transient PO2mv profile found in the present investigation. 
Model Considerations 
Electrical stimulation produces a fiber recruitment pattern that is dissimilar to that 
found in vivo and may result in a very different response from that which occurs during 
voluntary exercise.  Notwithstanding this departure form voluntary contractions, the 
PO2mv profile so obtained agrees closely with the profile of muscle effluent venous PO2 
seen in studies of humans performing exercise (6, 34). 
The effects of repeated muscle contractions on muscle fatigue must be considered. 
Repeated contractions in aged rats may exacerbate the depletion of intramuscular 
phosphocreatine and glycogen stores. Depletion of these finite energy sources will 
ultimately contribute to muscle fatigue (86). In the present investigation muscle force 
production by the contracting spinotrapezius muscle was significantly reduced after 
antioxidant supplementation. However, throughout each trial the contracting 
spinotrapezius muscle force production did not fall significantly from minute zero to 
minute four and independent trials demonstrated that this contraction protocol could be 
continued > 30 min without discernable fatigue (K.F. Herspring, S.W. Copp, D.C. Poole 
and T.I. Musch, unpublished findings). Thus, there are no indications that fatigue 
secondary to the control bout of contractions could account for the decreased force 
production seen in the antioxidant trails. 
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Limitations 
In this study, young rats were not examined due to the presumption that young 
rats produce what is considered a “normal” amount of ROS, which is substantially less 
than that found for aged individuals (27, 35, 69, 80). Thus, when young healthy 
individuals begin to exercise, muscle force production potential is altered only slightly by 
increasing ROS production because these individuals shift the force production curve to 
the right where they reach their optimal contracting state (Figure 5-1). In addition, young 
rats illustrate a normal PO2mv profile (9, 11) and the infusion of antioxidants would likely 
produce detrimental effects on the PO2mv profile by generating a greater increase in the 
NO bioavailability leading to a negative outcome. Thus, we anticipated that antioxidant 
supplementation in a young healthy rat would not produce the positive findings that we 
found in the aged rats participating in this study. However, this remains to be 
demonstrated.  
Another potential limitation is that the aged rats (26-30 months) used in the 
present investigation may not demonstrate the same response as humans with respect to 
the key variables measured herein and it is also possible that the results of the male rats 
used in the present investigation may not translate directly to female rats. The 
spinotrapezius muscle in the rat is used to stabilize the scapula and alterations seen in the 
spinotrapezius after antioxidant supplementation may not represent other locomotor 
muscles, note disparate Q& m regions herein. However, the spinotrapezius muscle is 
comprised of a mosaic of muscle fiber types (22) and has oxidative capacity similar to the 
human quadriceps (54) and in this respect it represents a good comparison to the human 
locomotor muscle. Finally, it should be noted that we examined only one level of 
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submaximal contractions in the present investigation. Therefore, the possibility exists that 
other exercise intensities or durations may produce significantly different responses than 
those found in this study.  
Future Directions 
Antioxidants have a major modulatory effect on the PO2mv found at rest and 
during the transition from rest-to-exercise. However, the mechanisms associated with the 
antioxidant-induced PO2mv changes remain to be defined precisely. In this study, it can be 
reasoned that the magnitude of antioxidants administered was so great that it caused a 
negative effect on the contracting muscle at least with respect to contractile output. 
Therefore, in future studies it may be important to examine the effects of lower doses of 
antioxidants on PO2mv, Q& m and muscle function (i.e., force production). Future studies 
should be designed to help us understand the effects that NO and ROS may play in 
controlling PO2mv at rest and during the transition to exercise.  
Examination of the effects of antioxidants on the PO2mv in rats with CHF and 
diabetes could also provide valuable information. In the present investigation the PO2mv 
profile found for the aged rat before antioxidant supplementation was very similar to 
those found previously for rats with CHF and diabetes (10, 24). Specifically, we 
anticipate that the administration of antioxidants would produce similar effects on 
patients with CHF and diabetes as those found in our study. Finally, tempol and ascorbic 
acid were administered together in the present investigation. Administration of each 
antioxidant individually could be potentially important since both compounds work in 
different ways and could potentially produce different results when administered 
separately.  
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Conclusion 
Antioxidant supplementation significantly alters the balance between Q& O2m and  
V
.
O2m at rest and following the onset of muscle contractions which modifies the 
microvascular PO2mv profile. Specifically, antioxidants elevate PO2mv at rest which 
improves the potential for diffusive blood-myocyte O2 flux. This effect arises, in part, 
from the unanticipated fall in muscle force production consequent to antioxidant 
supplementation rather than an elevated Q& O2m. 
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Figure 5-1: Biphasic Muscle Force Production Curve 
 
Biphasic response of muscle force production coupled with redox state. Open circle is the 
muscle force production by aged rats before antioxidant supplementation. Closed circle is 
the muscle force production by aged rats after antioxidant supplementation. Young 
healthy rats are indicated by the X. Drawn from the concept described by Reid and 
Durham (69). 
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